Gene · 2348
Papers3,253
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 3,253
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| SLC46A1 deficiency-mediated folate restriction suppresses colorectal cancer progression through epigenetic-transcriptional reprogramming. | Cell Death Dis | 2026 | 41620398 | PubTator, text mining | PubMed |
| Mirvetuximab soravtansine-Gynx (MIRV) for treating platinum-resistant recurrent ovarian cancer. | Taiwan J Obstet Gynecol | 2026 | 41617329 | PubTator, text mining | PubMed |
| Unlocking Ethiopia's genomic landscape and its global significance: a call for inclusive genomics research. | Hum Genomics | 2026 | 41612491 | PubTator, text mining | PubMed |
| Synthesis of Folic Acid-Functionalized Hybrid Mesoporous Silica Nanoparticles and In Vitro Evaluation on MCF-7 Breast Cancer Cells. | Int J Mol Sci | 2026 | 41596732 | PubTator, text mining | PubMed |
| Evaluating a data-driven approach to biomarker discovery for tumor-targeted imaging in epithelial ovarian cancer. | Biomarkers | 2026 | 41586462 | PubTator, text mining | PubMed |
| Synthetic zipper mediated pre-targeting system for near-infrared photoimmunotherapy. | iScience | 2026 | 41585490 | PubTator, text mining | PubMed |
| Profiling of Extracellular Vesicles of Non-Small Cell Lung Cancer Reveals Proteins Associated With Osimertinib Resistance. | J Extracell Vesicles | 2026 | 41581122 | PubTator, text mining | PubMed |
| Expression of antibody drug conjugate target antigens in ovarian sex cord stromal Tumors. | Gynecol Oncol | 2026 | 41576550 | PubTator, text mining | PubMed |
| Major clinical advances in gynecologic cancer in 2025: from de-escalation strategies to precision therapies beyond BRCA. | J Gynecol Oncol | 2026 | 41575332 | PubTator, text mining | PubMed |
| Gynecologic cancers in 2025: a year in review. | Int J Gynecol Cancer | 2026 | 41564592 | PubTator, text mining | PubMed |
| Targeted Co-Delivery of Bioactives via Inhalable Folic Acid-Functionalized Chitosan Microparticles Induces Immunomodulation and Selective Cytokine Production in A549 Lung Cancer Cells. | Macromol Biosci | 2026 | 41556916 | PubTator, text mining | PubMed |
| Engineering a fifth-generation CAR T cells to overcome PD-L1-mediated immunosuppression in lung cancer. | Biomed Pharmacother | 2026 | 41548539 | PubTator, text mining | PubMed |
| <p>Tumor microenvironment in bone sarcomas: Implications for immunotherapy and emerging therapeutic vulnerabilities (Review)</p>. | Oncol Rep | 2026 | 41543186 | PubTator, text mining | PubMed |
| Mirvetuximab Soravtansine: Mechanism of Action, Clinical and Translational Science. | Clin Transl Sci | 2026 | 41540835 | PubTator, text mining | PubMed |
| Supplementary biomarker testing in molecular tumor boards increases actionable therapy recommendations: a prospective real-world study of 658 patients. | BMC Med | 2026 | 41530754 | PubTator, text mining | PubMed |
| NIR-II Polymer Dots for Real-Time Navigating Hepatic Resection and Hepatic Ischemia-Reperfusion Injury. | ACS Appl Bio Mater | 2026 | 41524222 | PubTator, text mining | PubMed |
| Disposable electrochemical panel immunosensing systems for the simultaneous detection of potential biomarkers of ovarian cancer. | Mikrochim Acta | 2026 | 41518408 | PubTator, text mining | PubMed |
| Performance of the VENTANA FOLR1 Assay for folate receptor alpha: Real-world evidence from 313 Chinese participants. | Pathol Res Pract | 2026 | 41512768 | PubTator, text mining | PubMed |
| Current Developments of CAR-T and CAR-NK Cell Therapies for Ovarian Cancer. | Stem Cell Rev Rep | 2026 | 41455063 | PubTator, text mining | PubMed |
| Porous composite materials driven by carbohydrate-carbohydrate interactions for efficient enrichment of intact glycopeptides in liver cancer cells. | Talanta | 2026 | 41448058 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2348/papers?page=8